SciVision Biotech Inc
TWSE:1786
SciVision Biotech Inc
Research & Development
SciVision Biotech Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
SciVision Biotech Inc
TWSE:1786
|
Research & Development
-NT$80.9m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-10%
|
|
|
M
|
Medtecs International Corporation Ltd
SGX:546
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
V
|
Visco Vision Inc
TWSE:6782
|
Research & Development
-NT$201.5m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
P
|
Pegavision Corp
TWSE:6491
|
Research & Development
-NT$640.5m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
OK Biotech Co Ltd
TWSE:4155
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
SciVision Biotech Inc
Glance View
SciVision Biotech, Inc. engages in the research, development, and production of hyaluronic acid medical products. The company is headquartered in Kaohsiung, Kaohsiung. The company went IPO on 2010-12-29. The firm primarily provides subcutaneous fillers for plastic surgery facial injection, joint cavity injections for orthopedics use, as well as hyaluronic acid raw materials, among others. The firm is also involved in deoxyribonucleic acid (DNA) identification, detection, sequencing and application, as well as the manufacturing of care products and foods. The firm operates its business in the Americas, Europe, Asia, Middle East and Africa.
See Also
What is SciVision Biotech Inc's Research & Development?
Research & Development
-80.9m
TWD
Based on the financial report for Sep 30, 2025, SciVision Biotech Inc's Research & Development amounts to -80.9m TWD.
What is SciVision Biotech Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-10%
Over the last year, the Research & Development growth was -34%. The average annual Research & Development growth rates for SciVision Biotech Inc have been -12% over the past three years , -9% over the past five years , and -10% over the past ten years .